Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,563,984 $ 4,992,145
Investments 21,963,818 21,253,866
Vendor receivable 173,499
Prepaid expenses and other current assets 375,381 527,380
Total current assets 23,903,183 26,946,890
Property and equipment, net 228,117 260,612
Intangible assets, net 19,003 19,309
Other assets 76,596 69,620
Total assets 24,226,899 27,296,431
Current liabilities:    
Accounts payable 640,693 371,993
Accrued liabilities 136,785 196,020
Accrued payroll and other compensation 446,320 754,314
Note payable, net of debt discount and offering costs of $0 and $8,723 as of March 31, 2022 and December 31,2021, respectively 366,277
Total liabilities 1,223,798 1,688,604
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, Authorized 5,000,000 shares; No shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value, Authorized 180,000,000 shares; Issued and outstanding 86,981,684 shares as of March 31, 2022 and 86,339,567 as of December 31, 2021 86,982 86,340
Additional paid-in capital 110,911,954 110,255,549
Accumulated deficit (87,995,835) (84,734,062)
Total stockholders’ equity 23,003,101 25,607,827
Total liabilities and stockholders’ equity $ 24,226,899 $ 27,296,431